Clinical Trial Update: Antiproteinuric Agents and Fabry Disease

View source ↗

Summary

This clinical trial update reports a completed study evaluating antiproteinuric agents in Fabry disease with proteinuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Fabry Disease, Proteinuria | Status: COMPLETED